−0.4379 USD
−2.54 M USD
0.00 USD
33.42 M
About CERo Therapeutics Holdings, Inc.
Sector
Industry
CEO
Christopher B. Ehrlich
Website
Headquarters
Oakland
Founded
2021
FIGI
BBG012LSLG64
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CERO is 0.2479 USD — it has decreased by −0.44% in the past 24 hours. Watch CERo Therapeutics Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CERo Therapeutics Holdings, Inc. stocks are traded under the ticker CERO.
CERO stock has risen by 19.26% compared to the previous week, the month change is a 188.02% rise, over the last year CERo Therapeutics Holdings, Inc. has showed a −97.73% decrease.
CERO reached its all-time high on Feb 6, 2024 with the price of 12.8000 USD, and its all-time low was 0.0636 USD and was reached on Nov 6, 2024. View more price dynamics on CERO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CERO stock is 20.42% volatile and has beta coefficient of −5.66. Track CERo Therapeutics Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is CERo Therapeutics Holdings, Inc. there?
Today CERo Therapeutics Holdings, Inc. has the market capitalization of 12.78 M, it has increased by 32.91% over the last week.
Yes, you can track CERo Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
CERO net income for the last quarter is −4.23 M USD, while the quarter before that showed −2.45 M USD of net income which accounts for −72.66% change. Track more CERo Therapeutics Holdings, Inc. financial stats to get the full picture.
No, CERO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 9.00 employees. See our rating of the largest employees — is CERo Therapeutics Holdings, Inc. on this list?
Like other stocks, CERO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CERo Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CERo Therapeutics Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CERo Therapeutics Holdings, Inc. stock shows the sell signal. See more of CERo Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.